MGREMEDIUM SIGNALFINANCIAL10-K

MGRE reported substantially higher operating income alongside a significant reduction in cash position from $950M to $586M, while share count decreased to 26.7M shares.

The meaningful expansion in operating income combined with the reduced share count suggests active capital deployment through share repurchases, which aligns with management's stated capital allocation priorities. However, the $364M decline in cash reserves may limit near-term flexibility for growth investments or additional buybacks.

Comparing 2026-02-17 vs 2025-02-14View on EDGAR →
FINANCIAL ANALYSIS

MGRE demonstrated strong operational performance with operating income growing substantially and net income increasing 40.1% to $716.6M. The company's cash position declined significantly from $950M to $586M while share count fell from 29.3M to 26.7M shares, indicating aggressive share repurchase activity. Total liabilities increased 14.4% to $4.8B, though current liabilities actually decreased 10%, suggesting the company is managing its capital structure while returning significant capital to shareholders.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+79.4%
$3.4M→$6.1M

Capital expenditure jumped 79.4% — major investment cycle underway; assess returns on deployment.

Operating Income
P&L
+57.1%
$705.3M→$1.1B

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+40.1%
$511.6M→$716.6M

Net income grew 40.1% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
-38.3%
$950.0M→$586.0M

Cash declined 38.3% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Accounts Receivable
Balance Sheet
+18.9%
$214.9M→$255.5M

Receivables grew 18.9% — monitor days sales outstanding for collection efficiency.

Total Liabilities
Balance Sheet
+14.4%
$4.2B→$4.8B

Liabilities increased 14.4% — monitor debt-to-equity ratio and interest coverage.

Current Liabilities
Balance Sheet
-10%
$417.6M→$375.8M

Current liabilities reduced — improved short-term financial position and working capital health.

LANGUAGE CHANGES
NEW — 2026-02-17
PRIOR — 2025-02-14
ADDED
There were 26,684,730 shares of the registrant s common stock outstanding on February 12, 2026 .
We believe that high-quality, partner-owned firms have fundamental competitive advantages in meeting client objectives.
Our business generates significant cash flow, which we deploy toward growth investments and the return of capital to shareholders.
Our growth investments are focused on: (i) partnering with high-quality new Affiliates operating in areas of durable client demand; (ii) investing in and alongside our existing Affiliates to capitalize on their growth opportunities, including by seeding new products; and (iii) investing in our own strategic value-add capabilities, which are leveraged by our Affiliates to further scale and diversify their businesses.
As part of our strategy, we consistently evaluate our forward opportunity set; over the last several years, we have further invested in alternative strategies, including significant capital deployed toward new investments in fast- growing areas within private markets and liquid alternatives aligned with long-term trends.
+7 more — sign up free →
REMOVED
There were 29,257,014 shares of the registrant s common stock outstanding on February 12, 2025 .
We believe that high-quality, partner-own ed firms have fundamental competitive advantages in meeting client objectives.
Our business generates significant cash flow, which we deploy toward growth investments and return of capital to shareholders, primarily through share repurchases.
Our growth investments are focused on: (i) partnering with high-quality new Affiliates operating in secular demand areas; (ii) investing in and alongside our existing Affiliates to capitalize on their growth opportunities, including through seeding new products; and (iii) investing in our own strategic value-add capabilities, which are leveraged by our Affiliates to further scale and diversify their organizations.
As part of our strategy, we consistently evaluate our forward opportunity set; over the last several years, we have further invested in alternative strategies, including private markets and liquid alternatives.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →